18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
To determine if olmesartan plus amlodipine combination therapy alone and with
hydrochlorothiazide will be safe and effective to reduce high blood pressure in hypertensive,
type 2 diabetic subjects.